FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/05/2023
Voltar para busca
Dado oficial do USPTO
STRIKE PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
STRIKE PHARMA
ST13
US500000079317845Classe
1, 5, 10, 42
Pedido
79317845
Registro
6970244
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
30/05/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42
Data de depósito
22/06/2021
Data de registro
07/02/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/02/2023
Última transação
07/02/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
09
Localização do titular
SE
Examinador
HAN, DAWN
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Strike Pharma AB
Representantes
Donna J. Bunton NIXON & VANDERHYE P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry for production of antibodies and synthetic and natural peptides
Classe 5
Pharmaceutical preparations for human use for the treatment and prevention of diseases and conditions in the areas of immunologyoncologyimmune-oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmology; veterinary preparations for the treatment and prevention of diseases and conditions in the areas of immunologyoncologyimmune-oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmology; vaccines; therapeutic medicines for the treatment and prevention of diseases and conditions in the areas of immunologyoncologyimmune-oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmology; pharmaceutical preparations for the treatment of diseases and conditions in the areas of immunologyoncologyimmuno-oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmology; therapeutic antibodies for the treatment and prevention of diseases and conditions in the areas of immunologyoncologyimmune-oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmology
Classe 10
Delivery systems in the nature of implantable drug delivery ports for the deferredcontrolled or immediate release of active substances of pharmaceutical preparations; inhalers for medical use; syringes for injection and medical purposes
Classe 42
Research and development within the biologicalpharmacologicalveterinarymicrobiologicalbiomedicalpharmabioticalbiotherapeutical and biotechnological areas; research and development of new products featuring a synthetic antibody library including methods for selection and screening of such; research and development in the area of personalized medicine; medical laboratory services related to production of antibodies; research and development in the area of antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/05/2023
FIMP
FINAL DISPOSITION PROCESSED
08/05/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/05/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/02/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/01/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/11/2022
PUBO
PUBLISHED FOR OPPOSITION
22/11/2022
GPNX
NOTIFICATION PROCESSED BY IB
21/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/11/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/11/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/10/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
25/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
25/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/05/2022
RFNT
REFUSAL PROCESSED BY IB
04/04/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/03/2022
RFRR
REFUSAL PROCESSED BY MPU
17/03/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/02/2022
CNRT
NON-FINAL ACTION WRITTEN
16/02/2022
DOCK
ASSIGNED TO EXAMINER
07/02/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
20/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/08/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace STRIKE PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.